Department of Urology, Emory University School of Medicine, Atlanta, GA.
Department of Urology, Emory University School of Medicine, Atlanta, GA; Winship Cancer Institute, Emory Healthcare, Atlanta, GA.
Clin Genitourin Cancer. 2018 Aug;16(4):e705-e710. doi: 10.1016/j.clgc.2018.01.004. Epub 2018 Feb 2.
Enhanced recovery pathways after radical cystectomy attempt to decrease length of hospitalization, but might increase risk of readmission after discharge. We evaluated the relationship between length of stay and readmission after uncomplicated hospitalization for bladder cancer patients treated with radical cystectomy.
Using the American College of Surgeons National Surgical Quality Improvement Program database, we identified bladder cancer patients who were treated with radical cystectomy from 2011 to 2015. We limited this cohort to those who did not have complications captured while in-hospital, and assessed the proportion readmitted within 30 days of surgery on the basis of length of stay (ie, < 7, 7-9, ≥ 10 days). We fit multivariable logistic regression models to estimate odds of readmission after adjusting for potential confounding factors.
Among 4624 patients treated with radical cystectomy, 1003 (21.7%) were readmitted within 30 days of surgery. Of 1,003 readmitted patients, 503 (50%) experienced a major complication after discharge. Factors associated with an increased risk of readmission included diversion with neobladder, diabetes, prolonged surgical time, and obesity (all P < .01). Patients with hospitalization < 7 days were not at increased risk of readmission compared with those with prolonged stays (354/1769, 20.0% < 7 days vs. 201/968, 20.8% ≥ 10 days, adjusted odds ratio, 1.04; 95% confidence interval, 0.90-1.21).
In the absence of in-hospital complications after radical cystectomy, shorter hospitalizations were not associated with an increased risk of readmission. These findings emphasize the safety and potential cost savings of enhanced recovery pathways after these complex operations.
根治性膀胱切除术后的加速康复路径旨在缩短住院时间,但可能会增加出院后再次入院的风险。我们评估了无并发症住院的膀胱癌患者接受根治性膀胱切除术后的住院时间与再入院之间的关系。
我们使用美国外科医师学会国家手术质量改进计划数据库,确定了 2011 年至 2015 年间接受根治性膀胱切除术的膀胱癌患者。我们将该队列限制在那些住院期间没有发生并发症的患者,并根据住院时间(即<7、7-9、≥10 天)评估手术后 30 天内再入院的比例。我们拟合多变量逻辑回归模型,以调整潜在混杂因素后估计再入院的几率。
在接受根治性膀胱切除术的 4624 例患者中,有 1003 例(21.7%)在手术后 30 天内再次入院。在 1003 例再入院患者中,有 503 例(50%)在出院后出现主要并发症。与再入院风险增加相关的因素包括带造口袋的尿流改道、糖尿病、手术时间延长和肥胖(均 P<0.01)。与长时间住院的患者相比,住院时间<7 天的患者再入院风险没有增加(354/1769,20.0%<7 天 vs. 201/968,20.8%≥10 天,调整后的优势比,1.04;95%置信区间,0.90-1.21)。
在根治性膀胱切除术后无院内并发症的情况下,较短的住院时间与再入院风险增加无关。这些发现强调了这些复杂手术后强化康复途径的安全性和潜在的成本节约。